Hikma Adds Remsima SC To Celltrion MENA Collaboration

Subcutaneous Version Of Infliximab Joins Three Other Celltrion Biosimilars

 
• By Dave Wallace
  
MENA
Remsima SC joins Hikma’s MENA alliance with Celltrion • Source: Alamy

More from Deals

More from Business